Literature DB >> 23174104

A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation.

Emilia Daniłowicz-Luebert1, Svenja Steinfelder, Anja A Kühl, Gennadiy Drozdenko, Richard Lucius, Margitta Worm, Eckard Hamelmann, Susanne Hartmann.   

Abstract

Helminth parasites modulate the immune system by complex mechanisms to ensure persistence in the host. Released immunomodulatory parasite components lead to a beneficial environment for the parasite by targeting different host cells and in parallel to a modulation of unrelated inflammatory responses in the host, such as allergy. The aim of this study was to investigate the effect of the potent helminth immunomodulator, filarial cystatin, in a murine model of airway inflammation and hyperreactivity induced by a clinically relevant aeroallergen (timothy grass (Phleum pratense) pollen) and on the function of peripheral blood mononuclear cells (PBMCs) from timothy grass pollen allergic patients. BALB/c mice were systemically sensitised with a recombinant major allergen of timothy grass pollen (rPhl p 5b) and then challenged with timothy grass pollen extract (GPE) via the airways. Filarial cystatin was applied i.p. during the sensitisation phase. Airway hyperresponsiveness to methacholine challenges, inflammation of airways, inflammatory cell recruitment, cytokine production and lung histopathology were investigated. In a translational approach, PBMCs from allergic subjects and healthy controls were treated in vitro with cystatin prior to stimulation with GPE. Administration of filarial cystatin suppressed rPhl p 5b-induced allergen-specific Th2-responses and airway inflammation, inhibited local recruitment of eosinophils, reduced levels of allergen-specific IgE and down-regulated IL-5 and IL-13 in the bronchoalveolar lavage (BAL). Ex vivo restimulation with cystatin of spleen cells from cystatin-treated mice induced the production of IL-10, while cystatin inhibited allergen-specific IL-5 and IL-13 levels. Human PBMCs from timothy grass pollen allergic patients displayed a shift towards a Th1 response after treatment with cystatin. These results show that filarial cystatin ameliorates allergic inflammation and disease in a clinically relevant model of allergy. This data indicate that filarial cystatin has a modulatory effect on grass pollen-specific responses warranting further investigation of potential preventive and therapeutic options in the treatment of allergies.
Copyright © 2012 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174104     DOI: 10.1016/j.ijpara.2012.10.014

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  22 in total

1.  A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation.

Authors:  Rose A Whelan; Sebastian Rausch; Friederike Ebner; Dorothee Günzel; Jan F Richter; Nina A Hering; Jörg-Dieter Schulzke; Anja A Kühl; Ahmed Keles; Pawel Janczyk; Karsten Nöckler; Lothar H Wieler; Susanne Hartmann
Journal:  Mol Ther       Date:  2014-07-02       Impact factor: 11.454

Review 2.  Parasites and asthma.

Authors:  Lin Wuhao; Chen Ran; He Xujin; Wu Zhongdao; Paron Dekumyoy; Lv Zhiyue
Journal:  Parasitol Res       Date:  2017-07-08       Impact factor: 2.289

Review 3.  The immunology of the allergy epidemic and the hygiene hypothesis.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Immunol       Date:  2017-09-19       Impact factor: 25.606

4.  Helminth infections decrease host susceptibility to immune-mediated diseases.

Authors:  Joel V Weinstock; David E Elliott
Journal:  J Immunol       Date:  2014-10-01       Impact factor: 5.422

Review 5.  Allergy and worms: let's bring back old friends?

Authors:  Irma Schabussova; Ursula Wiedermann
Journal:  Wien Med Wochenschr       Date:  2014-10-04

Review 6.  Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?

Authors:  Svenja Steinfelder; Noëlle Louise O'Regan; Susanne Hartmann
Journal:  PLoS Pathog       Date:  2016-04-21       Impact factor: 6.823

7.  Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES-62 against clinically relevant allergens.

Authors:  L Janicova; J Rzepecka; D T Rodgers; J Doonan; K S Bell; F E Lumb; C J Suckling; M M Harnett; W Harnett
Journal:  Parasite Immunol       Date:  2016-06       Impact factor: 2.280

Review 8.  Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.

Authors:  Suguru Shigemori; Takeshi Shimosato
Journal:  Front Immunol       Date:  2017-01-25       Impact factor: 7.561

9.  Nematode-derived proteins suppress proliferation and cytokine production of antigen-specific T cells via induction of cell death.

Authors:  Wiebke Hartmann; Yannick Brenz; Manchang Tanyi Kingsley; Irene Ajonina-Ekoti; Norbert W Brattig; Eva Liebau; Minka Breloer
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

10.  The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.

Authors:  Martijn J Schuijs; Susanne Hartmann; Murray E Selkirk; Luke B Roberts; Peter J M Openshaw; Corinna Schnoeller
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.